Aryl imidazoles and their use as anticancer agents
Details for Australian Patent Application No. 2004289539 (hide)
International Classifications
Event Publications
8 June 2006 PCT application entered the National Phase
PCT publication WO2005/047266 Priority application(s): WO2005/047266
30 August 2007 Assignment before Grant
Lorus Therapeutics Inc. The application has been assigned to GeneSense Technologies Inc.
4 October 2007 Amendment Made
The nature of the amendment is: Add co-inventor Lock, Lisa
16 July 2009 Assignment before Grant
GeneSense Technologies Inc. The application has been assigned to Lorus Therapeutics Inc.
24 November 2011 Application Accepted
Published as AU-B-2004289539
16 February 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2012. Address for service in Australia - Lesicar Murray Trento PO Box 2545 Kent Town SA 5071 2005
7 June 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2012 2005
14 June 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004289540-Laminated body support element
2004289534-Apparatus and method for reducing and removing airborne oxidized particulates
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser